EPZM Epizyme Inc

Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

As of 07/29/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/31/2013
Outstanding shares:  168,364,752
Average volume:  3,506,859
Market cap:   $84,135,712
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B9Z1QZ7
Valuation   (See tab for details)
PE ratio:   -1.05
PB ratio:   1.73
PS ratio:   2.19
Return on equity:   -2,125.29%
Net income %:   -614.06%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy